Cargando…
Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence
SIMPLE SUMMARY: Valproic acid (VPA) is a well-known antiepileptic medication and mood stabiliser that is frequently prescribed for the treatment of epilepsy, particularly in children, and has proven human teratogenic activity. VPA inhibits histone deacetylase, which causes teratogenicity and cell to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772829/ https://www.ncbi.nlm.nih.gov/pubmed/35053076 http://dx.doi.org/10.3390/biology11010079 |
_version_ | 1784635936173195264 |
---|---|
author | Gouda, Balaji Sinha, Sukesh Narayan Chalamaiah, Meram Vakdevi, Validandi Shashikala, Patangay Veeresh, Bantal Surekha, Venkata Mullapudi Kasturi, Vasudev Boiroju, Naveen Kumar |
author_facet | Gouda, Balaji Sinha, Sukesh Narayan Chalamaiah, Meram Vakdevi, Validandi Shashikala, Patangay Veeresh, Bantal Surekha, Venkata Mullapudi Kasturi, Vasudev Boiroju, Naveen Kumar |
author_sort | Gouda, Balaji |
collection | PubMed |
description | SIMPLE SUMMARY: Valproic acid (VPA) is a well-known antiepileptic medication and mood stabiliser that is frequently prescribed for the treatment of epilepsy, particularly in children, and has proven human teratogenic activity. VPA inhibits histone deacetylase, which causes teratogenicity and cell toxicity. VPA-induced autism in rodents during the pre- and postnatal periods has shown the development of an autism-like phenotype. In mice, the 14th postnatal day is thought to correspond to the third trimester of human development; it is an important period in which neuronal migration, differentiation, myelination, synaptogenesis and gliogenesis occur in the cerebellum, striatum and hippocampus. Therefore, we exposed postnatal day 14 (PND 14) mice to VPA, which resulted in autistic-like behaviours manifested as reduced social interaction, increased repetitive stereotyped behaviour and anxiety, cognitive dysfunction, lowered sensitivity to pain and neurodevelopmental delay. BALB/c mice were used in this work because they are less reactive to social contact in VPA-induced autism than many other inbred mouse strains, such as C57/129 mice. In humans, two to three times more men are affected by autism spectrum disorder (ASD) than women, and, for this reason, the current study compares the histopathological changes and 5-hydroxy-tryptamine 2A (5-HT2A) receptor protein expression in the brain tissue of male and female animals with VPA-induced autism. ABSTRACT: Autism spectrum disorder (ASD) is characterised by problems with social interaction, verbal and nonverbal communication and repetitive behaviour. In mice, the 14th postnatal day is believed to correspond to the third trimester of human embryonic development and is considered a vital period for central nervous system development. It has been shown that ASD affects 2 to 3 times more male than female individuals. In the present study, ASD was induced in 14 postnatal day (PND) BALB/c mice using valproic acid (VPA). VPA administration brought about substantial differences in the histoarchitecture of the brain in both male and female mice, linked to behavioural deficits. We observed that both male and female mice showed similar morphological changes in the prefrontal cortex, hippocampus and Purkinje cells. We also observed hair loss from PND 17 to 25, which was again similar between male and female mice. However, there were higher rates of change in the cerebral cortex, frontal cortex and temporal lobe and hippocampus in VPA-treated male animals. With respect to the cerebellum, we did not observe any alterations by haematoxylin and eosin (H&E) staining, but detailed morphological observation using scanning electron microscopy (SEM) showed a higher rate of phenotype changes in VPA-treated male animals. Moreover, 5-HT2A receptor protein levels were upregulated in the cerebral cortex, hippocampus and Purkinje cells in VPA-treated male mice compared with control animals and VPA-treated female mice, as shown by immunohistochemical analysis. Based on all these findings, we conclude that male animals are more susceptible to VPA-induced ASD than females. |
format | Online Article Text |
id | pubmed-8772829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87728292022-01-21 Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence Gouda, Balaji Sinha, Sukesh Narayan Chalamaiah, Meram Vakdevi, Validandi Shashikala, Patangay Veeresh, Bantal Surekha, Venkata Mullapudi Kasturi, Vasudev Boiroju, Naveen Kumar Biology (Basel) Article SIMPLE SUMMARY: Valproic acid (VPA) is a well-known antiepileptic medication and mood stabiliser that is frequently prescribed for the treatment of epilepsy, particularly in children, and has proven human teratogenic activity. VPA inhibits histone deacetylase, which causes teratogenicity and cell toxicity. VPA-induced autism in rodents during the pre- and postnatal periods has shown the development of an autism-like phenotype. In mice, the 14th postnatal day is thought to correspond to the third trimester of human development; it is an important period in which neuronal migration, differentiation, myelination, synaptogenesis and gliogenesis occur in the cerebellum, striatum and hippocampus. Therefore, we exposed postnatal day 14 (PND 14) mice to VPA, which resulted in autistic-like behaviours manifested as reduced social interaction, increased repetitive stereotyped behaviour and anxiety, cognitive dysfunction, lowered sensitivity to pain and neurodevelopmental delay. BALB/c mice were used in this work because they are less reactive to social contact in VPA-induced autism than many other inbred mouse strains, such as C57/129 mice. In humans, two to three times more men are affected by autism spectrum disorder (ASD) than women, and, for this reason, the current study compares the histopathological changes and 5-hydroxy-tryptamine 2A (5-HT2A) receptor protein expression in the brain tissue of male and female animals with VPA-induced autism. ABSTRACT: Autism spectrum disorder (ASD) is characterised by problems with social interaction, verbal and nonverbal communication and repetitive behaviour. In mice, the 14th postnatal day is believed to correspond to the third trimester of human embryonic development and is considered a vital period for central nervous system development. It has been shown that ASD affects 2 to 3 times more male than female individuals. In the present study, ASD was induced in 14 postnatal day (PND) BALB/c mice using valproic acid (VPA). VPA administration brought about substantial differences in the histoarchitecture of the brain in both male and female mice, linked to behavioural deficits. We observed that both male and female mice showed similar morphological changes in the prefrontal cortex, hippocampus and Purkinje cells. We also observed hair loss from PND 17 to 25, which was again similar between male and female mice. However, there were higher rates of change in the cerebral cortex, frontal cortex and temporal lobe and hippocampus in VPA-treated male animals. With respect to the cerebellum, we did not observe any alterations by haematoxylin and eosin (H&E) staining, but detailed morphological observation using scanning electron microscopy (SEM) showed a higher rate of phenotype changes in VPA-treated male animals. Moreover, 5-HT2A receptor protein levels were upregulated in the cerebral cortex, hippocampus and Purkinje cells in VPA-treated male mice compared with control animals and VPA-treated female mice, as shown by immunohistochemical analysis. Based on all these findings, we conclude that male animals are more susceptible to VPA-induced ASD than females. MDPI 2022-01-05 /pmc/articles/PMC8772829/ /pubmed/35053076 http://dx.doi.org/10.3390/biology11010079 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gouda, Balaji Sinha, Sukesh Narayan Chalamaiah, Meram Vakdevi, Validandi Shashikala, Patangay Veeresh, Bantal Surekha, Venkata Mullapudi Kasturi, Vasudev Boiroju, Naveen Kumar Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence |
title | Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence |
title_full | Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence |
title_fullStr | Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence |
title_full_unstemmed | Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence |
title_short | Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence |
title_sort | sex differences in animal models of sodium-valproate-induced autism in postnatal balb/c mice: whole-brain histoarchitecture and 5-ht2a receptor biomarker evidence |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772829/ https://www.ncbi.nlm.nih.gov/pubmed/35053076 http://dx.doi.org/10.3390/biology11010079 |
work_keys_str_mv | AT goudabalaji sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT sinhasukeshnarayan sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT chalamaiahmeram sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT vakdevivalidandi sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT shashikalapatangay sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT veereshbantal sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT surekhavenkatamullapudi sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT kasturivasudev sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence AT boirojunaveenkumar sexdifferencesinanimalmodelsofsodiumvalproateinducedautisminpostnatalbalbcmicewholebrainhistoarchitectureand5ht2areceptorbiomarkerevidence |